Back to search
Prevention of Thromboembolic Events
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Thromboembolic Events trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prevention of Thromboembolic Events trials you may qualify forThis study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side)…
This study is researching an experimental drug called REGN7508 versus Acetylsalicylic Acid (ASA) (each called "study drug"). The study is focused on adults unde…
This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brai…
This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on the prevention of Cancer-Associated Thrombosis (CA…
The objective of this randomized clinical trial is to evaluate the safety and efficiency of different anticoagulation schemes with heparin for venous thromboemb…
Philadelphia-negative myeloproliferative neoplasms (MPN) are frequent and chronic myeloid malignancies including Polycythemia Vera (PV), essential thrombocythem…
This is an observational study in which the data from children with congenital heart disease will be collected and studied. These children will include those wh…
The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplas…